Facebook Instagram Pinterest Reddit Tumblr X Youtube
  • Home
  • About
  • News
  • Events
  • Shop
  • Directory
  • Contact Us
Search
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.
PsyNews.com
  • Home
  • About
  • News
  • Events
  • Shop
  • Directory
  • Contact Us
Home Featured Page 178

Featured

Latest
  • Latest
  • Featured posts
  • Most popular
  • 7 days popular
  • By review score
  • Random

Shroomski Melt

Psychedelic Policy Briefing: June 11, 2026

May 2026 Psychedelic Bill Roundup

Utah’s Quiet Revolution: Why HB 390 May Be the Most Significant Psychedelic Legislation of 2026

Field Notes #2: Dispatches from London and the Netherlands

Yale’s Department of Psychiatry Chair to Join Clearmind Medicine

Mindset Pharma and Top Psychiatric Research Hospital, CAMH, Enter Innovative Collaboration...

Diamond Therapeutics Achieves Last Patient Last Visit in Clinical Trial of...

Gilgamesh Announces Clinical Candidates For Two Programs With First In Human...

Bexson Biomedical to present at the H.C. Wainwright and Beryl Elites...

Psilera Expands Computational Chemistry Abilities with the Addition of Dr. Daniel...

Danish Synthetic Biology Drug Developer Octarine and British Clinical Research Organisation...

CB Therapeutics granted a new patent that will help further provide...

Wake Network, Inc. Receives Certificate of Drug Registration for Microdose Formulation...

Braxia Scientific CEO to Deliver Keynote Address at H.C. Wainwright &...

Load more

EDITOR PICKS

Shroomski Melt

Psychedelic Policy Briefing: June 11, 2026

May 2026 Psychedelic Bill Roundup

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY

    ABOUT US
    PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.
    FOLLOW US
    Facebook Instagram Pinterest Reddit Tumblr X Youtube
    ©